Research Shows Medical Cannabis To Become a Major Part Of Pharmaceutical Market

Cannabis to make major impact on pharmaceutical marketplace

NEW YORK: According to a research report by New Frontier Data, medical marijuana sales are forecast to grow to $5.3 billion in 2017, accounting for 67% of total cannabis sales. Medical sales in currently legal states are forecast to grow to $13.2 billion by 2025, at which point medical sales will account for 55% of all sales. In comparison, adult-use Read the full article…

Study: Medical Cannabis Enrollees Reduce Their Prescription Drug Use

mmj is better than pills

ILLINOIS: Patients enrolled in a statewide medical cannabis program are likely to reduce their use of conventional prescription drugs over time, according to data published online ahead of print in The Journal of Alternative and Complementary Care. Investigators from DePaul University and Rush University, College of Nursing assessed prescription drug use patterns in 34 patients registered to use cannabis Read the full article…

Study: Marijuana Dispensaries Associated With Declining Rates Of Painkiller Abuse

Green is good

GEORGIA: Cannabis dispensaries are associated with reduced levels of opioid-related treatment admissions and overall drug mortality, according to a study published online on SSRN.com. A University of Georgia economics professor assessed the relationship between the opening of medical cannabis dispensaries and drug treatment admissions. Dispensary openings are associated with “a 20 percentage point relative decrease in painkiller treatment Read the full article…

Tilray Exports Medical Cannabis Products To New Zealand or Nationwide Distribution

Products currently available in New Zealand include precisely formulated medical cannabis oils containing tetrahydrocannabinol (THC) and cannabidiol (CBD).

CANADA: Tilray, a global leader in medical cannabis research and production, today announced that Tilray medical cannabis products have been successfully exported to New Zealand and are now available for distribution nationwide. The products were produced at Tilray’s federally licensed, Good Manufacturing Practice (GMP)-certified facility in Canada and can be dispensed to any patient with valid Read the full article…

Cannabis Science Pioneer Tikun Olam Expands Partnership With MariMed

Tikun Olam

Combines Tikun Products & Unparalleled Research with MariMed’s Cultivation & Distribution Networks MASSACHUSETTS and NEW YORK:  Tikun Olam, the world pioneer in cannabis research, and MariMed Inc., a preeminent management company in the U.S. medical cannabis industry, announced an expansion of their licensing agreement for Tikun Olam products to be grown, manufactured and sold through MariMed’s Read the full article…

Nanoparticle Drones To Target Lung Cancer with Radiosensitizers And Cannabinoids

nanotechnology

Wilfred Ngwa1,2*, Rajiv Kumar1,3, Michele Moreau1,2, Raymond Dabney4 and Allen Herman4 1Department of Radiation Oncology, Dana-Farber Cancer Institute, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, United States 2University of Massachusetts Lowell, Lowell, MA, United States 3Northeastern University, Boston, MA, United States 4Cannabis Science Inc., Irvine, CA, United States   CALIFORNIA: Nanotechnology has opened up a new, previously unimaginable Read the full article…

Study: Cannabis Exposure Associated With Improved Immunity In HIV Patients

Doctors seek alternatives to opioids

PENNSYLVANIA:Patients with HIV who test positive for past cannabis exposure possess significantly higher CD4+ and CD8+ counts than do those patients who test negative for the substance, according to data published in the journal Drug and Alcohol Dependence. CD4+ and CD8+ cells are a subtype of white blood cells that assist in the immune process. A team of investigators from Read the full article…

International Collaborative Study Reveals The Neuroprotective Properties of Phytocannabinoid Δ9-THCA

A recent Δ9-THCA (Δ9-tetrahydrocannabinol acid) study, initiated by three leading companies active in the field of medicinal cannabis research, has demonstrated its ability as a promising treatment modality for Huntington's disease (HD) and other metabolic, neurodegenerative and neuroinflammatory diseases.

SPAIN:  Advanced medical research conducted at Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC) as a collaborative effort between Phytoplant Research SL, VivaCell Biotechnology España SL, and Emerald Health Pharmaceuticals has unveiled the potent neuroprotective ability of Δ9-THCA, a phytocannabinoid produced in Cannabis sativa L. The research paper was accepted and published in the British Journal of Pharmacology. Read the full article…

Study: No Link Between Cumulative Cannabis Use And Kidney Disease

No Link Between Cumulative Cannabis Use And Kidney Disease

CALIFORNIA:  Neither current nor the long-term cumulative use of cannabis is associated with negative effects on the kidneys, according to longitudinal data published online ahead of print in the Clinical Journal of the American Society of Nephrology. Investigators at the San Francisco Veterans Affairs Medical Center and the University of California, San Francisco assessed the impact of past Read the full article…

Mary’s Medicinals Coming To Maryland Medical Cannabis Patients

Mary's Medicinals Products Coming to Maryland

COLORADO: MM Technology Holdings has announced  a partnership with Green Thumb Industries (GTI) to produce and distribute its line of Mary’s Medicinals cannabis products for patients across Maryland. “Mary’s has developed a line of unique products with unparalleled quality, accuracy and an exceptional reputation for effectiveness,” said Ben Kovler, Founder and Chairman, GTI. “Patients deserve the choice of alternative forms of Read the full article…